{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:57Z","timestamp":1786980537167,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T00:00:00Z","timestamp":1573171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T00:00:00Z","timestamp":1573171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Japan Society for the Promotion of Science (JSPS) KAKENHI","award":["18K09006"],"award-info":[{"award-number":["18K09006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s10143-019-01185-2","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T10:35:55Z","timestamp":1573209355000},"page":"1583-1593","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Influence of wide opening of the lateral ventricle on survival for supratentorial glioblastoma patients with radiotherapy and concomitant temozolomide-based chemotherapy"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5016-9619","authenticated-orcid":false,"given":"Taiichi","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Muragaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Komori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Tsuzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takakazu","family":"Kawamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,8]]},"reference":[{"key":"1185_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1748-717X-9-95","volume":"9","author":"S Adeberg","year":"2014","unstructured":"Adeberg S, Bostel T, Konig L, Welzel T, Debus J, Combs SE (2014) A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival? Radiat Oncol 9:95. https:\/\/doi.org\/10.1186\/1748-717X-9-95","journal-title":"Radiat Oncol"},{"key":"1185_CR2","doi-asserted-by":"publisher","first-page":"e461","DOI":"10.1016\/j.wneu.2018.10.075","volume":"122","author":"Y Ahmadipour","year":"2019","unstructured":"Ahmadipour Y, Jabbarli R, Gembruch O, Pierscianek D, Darkwah Oppong M, Dammann P, Wrede K, Ozkan N, Muller O, Sure U, El Hindy N (2019) Impact of multifocality and molecular markers on survival of glioblastoma. World Neurosurg 122:e461\u2013e466. https:\/\/doi.org\/10.1016\/j.wneu.2018.10.075","journal-title":"World Neurosurg"},{"key":"1185_CR3","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756\u2013760. https:\/\/doi.org\/10.1038\/nature05236","journal-title":"Nature"},{"key":"1185_CR4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.wneu.2017.07.034","volume":"106","author":"F Behling","year":"2017","unstructured":"Behling F, Kaltenstadler M, Noell S, Schittenhelm J, Bender B, Eckert F, Tabatabai G, Tatagiba M, Skardelly M (2017) The prognostic impact of ventricular opening in glioblastoma surgery: a retrospective single center analysis. World Neurosurg 106:615\u2013624. https:\/\/doi.org\/10.1016\/j.wneu.2017.07.034","journal-title":"World Neurosurg"},{"key":"1185_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.wneu.2016.10.109","volume":"98","author":"A Fukui","year":"2017","unstructured":"Fukui A, Muragaki Y, Saito T, Maruyama T, Nitta M, Ikuta S, Kawamata T (2017) Volumetric analysis using low-field intraoperative magnetic resonance imaging for 168 newly diagnosed supratentorial glioblastomas: effects of extent of resection and residual tumor volume on survival and recurrence. World Neurosurg 98:73\u201380. https:\/\/doi.org\/10.1016\/j.wneu.2016.10.109","journal-title":"World Neurosurg"},{"key":"1185_CR6","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1212\/WNL.0b013e318212a89f","volume":"76","author":"X Gong","year":"2011","unstructured":"Gong X, Schwartz PH, Linskey ME, Bota DA (2011) Neural stem\/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy. Neurology 76:1126\u20131134. https:\/\/doi.org\/10.1212\/WNL.0b013e318212a89f","journal-title":"Neurology"},{"key":"1185_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11060-015-1818-x","volume":"124","author":"S Han","year":"2015","unstructured":"Han S, Li X, Qiu B, Jiang T, Wu A (2015) Can lateral ventricle contact predict the ontogeny and prognosis of glioblastoma? J Neuro-Oncol 124:45\u201355. https:\/\/doi.org\/10.1007\/s11060-015-1818-x","journal-title":"J Neuro-Oncol"},{"key":"1185_CR8","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997\u20131003. https:\/\/doi.org\/10.1056\/NEJMoa043331","journal-title":"N Engl J Med"},{"key":"1185_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/neuonc\/nos268","volume":"15","author":"NF Jafri","year":"2013","unstructured":"Jafri NF, Clarke JL, Weinberg V, Barani IJ, Cha S (2013) Relationship of glioblastoma multiforme to the subventricular zone is associated with survival. Neuro-Oncology 15:91\u201396. https:\/\/doi.org\/10.1093\/neuonc\/nos268","journal-title":"Neuro-Oncology"},{"key":"1185_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00432-003-0471-5","volume":"129","author":"B Jeremic","year":"2003","unstructured":"Jeremic B, Milicic B, Grujicic D, Dagovic A, Aleksandrovic J (2003) Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach. J Cancer Res Clin Oncol 129:477\u2013484. https:\/\/doi.org\/10.1007\/s00432-003-0471-5","journal-title":"J Cancer Res Clin Oncol"},{"key":"1185_CR11","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3171\/2016.7.JNS16340","volume":"127","author":"JK John","year":"2017","unstructured":"John JK, Robin AM, Pabaney AH, Rammo RA, Schultz LR, Sadry NS, Lee IY (2017) Complications of ventricular entry during craniotomy for brain tumor resection. J Neurosurg 127:426\u2013432. https:\/\/doi.org\/10.3171\/2016.7.JNS16340","journal-title":"J Neurosurg"},{"key":"1185_CR12","doi-asserted-by":"publisher","unstructured":"Jungk C, Warta R, Mock A, Friauf S, Hug B, Capper D, Abdollahi A, Debus J, Bendszus M, von Deimling A, Unterberg A, Herold-Mende C (2019) Location-dependent patient outcome and recurrence patterns in IDH1-wildtype glioblastoma. Cancers (Basel) 11. https:\/\/doi.org\/10.3390\/cancers11010122","DOI":"10.3390\/cancers11010122"},{"key":"1185_CR13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3171\/jns.2001.95.2.0190","volume":"95","author":"M Lacroix","year":"2001","unstructured":"Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190\u2013198. https:\/\/doi.org\/10.3171\/jns.2001.95.2.0190","journal-title":"J Neurosurg"},{"key":"1185_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/1078155211426198","volume":"18","author":"N Lam","year":"2012","unstructured":"Lam N, Chambers CR (2012) Temozolomide plus radiotherapy for glioblastoma in a Canadian province: efficacy versus effectiveness and the impact of O6-methylguanine-DNA-methyltransferase promoter methylation. J Oncol Pharm Pract 18:229\u2013238. https:\/\/doi.org\/10.1177\/1078155211426198","journal-title":"J Oncol Pharm Pract"},{"key":"1185_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41586-018-0389-3","volume":"560","author":"JH Lee","year":"2018","unstructured":"Lee JH, Lee JE, Kahng JY, Kim SH, Park JS, Yoon SJ, Um JY, Kim WK, Lee JK, Park J, Kim EH, Lee JH, Lee JH, Chung WS, Ju YS, Park SH, Chang JH, Kang SG, Lee JH (2018) Human glioblastoma arises from subventricular zone cells with low-level driver mutations. Nature 560:243\u2013247. https:\/\/doi.org\/10.1038\/s41586-018-0389-3","journal-title":"Nature"},{"key":"1185_CR16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1215\/15228517-2007-023","volume":"9","author":"DA Lim","year":"2007","unstructured":"Lim DA, Cha S, Mayo MC, Chen MH, Keles E, VandenBerg S, Berger MS (2007) Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro-Oncology 9:424\u2013429. https:\/\/doi.org\/10.1215\/15228517-2007-023","journal-title":"Neuro-Oncology"},{"key":"1185_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jocn.2018.01.009","volume":"50","author":"M Matsuda","year":"2018","unstructured":"Matsuda M, Kohzuki H, Ishikawa E, Yamamoto T, Akutsu H, Takano S, Mizumoto M, Tsuboi K, Matsumura A (2018) Prognostic analysis of patients who underwent gross total resection of newly diagnosed glioblastoma. J Clin Neurosci 50:172\u2013176. https:\/\/doi.org\/10.1016\/j.jocn.2018.01.009","journal-title":"J Clin Neurosci"},{"key":"1185_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11060-017-2374-3","volume":"132","author":"AM Mistry","year":"2017","unstructured":"Mistry AM, Dewan MC, White-Dzuro GA, Brinson PR, Weaver KD, Thompson RC, Ihrie RA, Chambless LB (2017) Decreased survival in glioblastomas is specific to contact with the ventricular-subventricular zone, not subgranular zone or corpus callosum. J Neuro-Oncol 132:341\u2013349. https:\/\/doi.org\/10.1007\/s11060-017-2374-3","journal-title":"J Neuro-Oncol"},{"key":"1185_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11060-016-2278-7","volume":"131","author":"AM Mistry","year":"2017","unstructured":"Mistry AM, Hale AT, Chambless LB, Weaver KD, Thompson RC, Ihrie RA (2017) Influence of glioblastoma contact with the lateral ventricle on survival: a meta-analysis. J Neuro-Oncol 131:125\u2013133. https:\/\/doi.org\/10.1007\/s11060-016-2278-7","journal-title":"J Neuro-Oncol"},{"key":"1185_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-3-211-33303-7_10","volume":"98","author":"Y Muragaki","year":"2006","unstructured":"Muragaki Y, Iseki H, Maruyama T, Kawamata T, Yamane F, Nakamura R, Kubo O, Takakura K, Hori T (2006) Usefulness of intraoperative magnetic resonance imaging for glioma surgery. Acta Neurochir Suppl 98:67\u201375","journal-title":"Acta Neurochir Suppl"},{"key":"1185_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-3-211-99651-5_11","volume":"109","author":"Y Muragaki","year":"2011","unstructured":"Muragaki Y, Iseki H, Maruyama T, Tanaka M, Shinohara C, Suzuki T, Yoshimitsu K, Ikuta S, Hayashi M, Chernov M, Hori T, Okada Y, Takakura K (2011) Information-guided surgical management of gliomas using low-field-strength intraoperative MRI. Acta Neurochir Suppl 109:67\u201372. https:\/\/doi.org\/10.1007\/978-3-211-99651-5_11","journal-title":"Acta Neurochir Suppl"},{"key":"1185_CR22","doi-asserted-by":"publisher","unstructured":"Nitta M, Muragaki Y, Maruyama T, Iseki H, Komori T, Ikuta S, Saito T, Yasuda T, Hosono J, Okamoto S, Koriyama S, Kawamata T (2018) Role of photodynamic therapy using talaporfin sodium and a semiconductor laser in patients with newly diagnosed glioblastoma. J Neurosurg:1\u20138. https:\/\/doi.org\/10.3171\/2018.7.JNS18422","DOI":"10.3171\/2018.7.JNS18422"},{"key":"1185_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.clon.2016.09.005","volume":"29","author":"B Nourallah","year":"2017","unstructured":"Nourallah B, Digpal R, Jena R, Watts C (2017) Irradiating the subventricular zone in glioblastoma patients: is there a case for a clinical trial? Clin Oncol (R Coll Radiol) 29:26\u201333. https:\/\/doi.org\/10.1016\/j.clon.2016.09.005","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1185_CR24","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA Jr, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807\u20131812. https:\/\/doi.org\/10.1126\/science.1164382","journal-title":"Science"},{"key":"1185_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.5114\/fn.2015.49974","volume":"53","author":"KM Pina Batista","year":"2015","unstructured":"Pina Batista KM, Vega IF, de Eulate-Beramendi SA, Morales J, Kurbanov A, Asnel D, Meilan A, Astudillo A (2015) Prognostic significance of the markers IDH1 and YKL40 related to the subventricular zone. Folia Neuropathol 53:52\u201359","journal-title":"Folia Neuropathol"},{"key":"1185_CR26","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1002\/cncr.27392","volume":"118","author":"V Quillien","year":"2012","unstructured":"Quillien V, Lavenu A, Karayan-Tapon L, Carpentier C, Labussiere M, Lesimple T, Chinot O, Wager M, Honnorat J, Saikali S, Fina F, Sanson M, Figarella-Branger D (2012) Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 glioblastoma patients. Cancer 118:4201\u20134211. https:\/\/doi.org\/10.1002\/cncr.27392","journal-title":"Cancer"},{"key":"1185_CR27","doi-asserted-by":"publisher","unstructured":"Roh TH, Kang SG, Moon JH, Sung KS, Park HH, Kim SH, Kim EH, Hong CK, Suh CO, Chang JH (2019) Survival benefit of lobectomy over gross-total resection without lobectomy in cases of glioblastoma in the noneloquent area: a retrospective study. J Neurosurg:1\u20137. https:\/\/doi.org\/10.3171\/2018.12.JNS182558","DOI":"10.3171\/2018.12.JNS182558"},{"key":"1185_CR28","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3171\/2016.11.JNS162326","volume":"128","author":"T Saito","year":"2018","unstructured":"Saito T, Sugiyama K, Takeshima Y, Amatya VJ, Yamasaki F, Takayasu T, Nosaka R, Muragaki Y, Kawamata T, Kurisu K (2018) Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide. J Neurosurg 128:679\u2013684. https:\/\/doi.org\/10.3171\/2016.11.JNS162326","journal-title":"J Neurosurg"},{"key":"1185_CR29","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/neuros\/nyy089","volume":"84","author":"T Saito","year":"2019","unstructured":"Saito T, Muragaki Y, Shioyama T, Komori T, Maruyama T, Nitta M, Yasuda T, Hosono J, Okamoto S, Kawamata T (2019) Malignancy index using intraoperative flow cytometry is a valuable prognostic factor for glioblastoma treated with radiotherapy and concomitant temozolomide. Neurosurgery 84:662\u2013672. https:\/\/doi.org\/10.1093\/neuros\/nyy089","journal-title":"Neurosurgery"},{"key":"1185_CR30","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1056\/NEJMra043666","volume":"353","author":"N Sanai","year":"2005","unstructured":"Sanai N, Alvarez-Buylla A, Berger MS (2005) Neural stem cells and the origin of gliomas. N Engl J Med 353:811\u2013822. https:\/\/doi.org\/10.1056\/NEJMra043666","journal-title":"N Engl J Med"},{"key":"1185_CR31","doi-asserted-by":"publisher","unstructured":"Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115:3-8. Doi:https:\/\/doi.org\/10.3171\/2011.2.JNS10998. https:\/\/doi.org\/10.3171\/2011.7.JNS10998","DOI":"10.3171\/2011.2.JNS10998 10.3171\/2011.7.JNS10998"},{"key":"1185_CR32","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S1470-2045(11)70196-6","volume":"12","author":"C Senft","year":"2011","unstructured":"Senft C, Bink A, Franz K, Vatter H, Gasser T, Seifert V (2011) Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol 12:997\u20131003. https:\/\/doi.org\/10.1016\/S1470-2045(11)70196-6","journal-title":"Lancet Oncol"},{"key":"1185_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11060-017-2488-7","volume":"134","author":"Y Sonoda","year":"2017","unstructured":"Sonoda Y, Shibahara I, Matsuda KI, Saito R, Kawataki T, Oda M, Sato Y, Sadahiro H, Nomura S, Sasajima T, Beppu T, Kanamori M, Sakurada K, Kumabe T, Tominaga T, Kinouchi H, Shimizu H, Ogasawara K, Suzuki M (2017) Opening the ventricle during surgery diminishes survival among patients with newly diagnosed glioblastoma treated with carmustine wafers: a multi-center retrospective study. J Neuro-Oncol 134:83\u201388. https:\/\/doi.org\/10.1007\/s11060-017-2488-7","journal-title":"J Neuro-Oncol"},{"key":"1185_CR34","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","volume":"7","author":"W Stummer","year":"2006","unstructured":"Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ, Group AL-GS (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392\u2013401. https:\/\/doi.org\/10.1016\/S1470-2045(06)70665-9","journal-title":"Lancet Oncol"},{"key":"1185_CR35","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for R, Treatment of Cancer Brain T, Radiotherapy G, National Cancer Institute of Canada Clinical Trials G (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"1185_CR36","doi-asserted-by":"publisher","unstructured":"van Dijken BRJ, Jan van Laar P, Li C, Yan JL, Boonzaier NR, Price SJ, van der Hoorn A (2018) Ventricle contact is associated with lower survival and increased peritumoral perfusion in glioblastoma. J Neurosurg:1\u20137. https:\/\/doi.org\/10.3171\/2018.5.JNS18340","DOI":"10.3171\/2018.5.JNS18340"},{"key":"1185_CR37","doi-asserted-by":"publisher","first-page":"5743","DOI":"10.1200\/JCO.2009.23.0805","volume":"27","author":"M Weller","year":"2009","unstructured":"Weller M, Felsberg J, Hartmann C, Berger H, Steinbach JP, Schramm J, Westphal M, Schackert G, Simon M, Tonn JC, Heese O, Krex D, Nikkhah G, Pietsch T, Wiestler O, Reifenberger G, von Deimling A, Loeffler M (2009) Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. J Clin Oncol 27:5743\u20135750. https:\/\/doi.org\/10.1200\/JCO.2009.23.0805","journal-title":"J Clin Oncol"},{"key":"1185_CR38","doi-asserted-by":"publisher","first-page":"e375","DOI":"10.1016\/j.wneu.2018.04.059","volume":"115","author":"P Woo","year":"2018","unstructured":"Woo P, Ho J, Lam S, Ma E, Chan D, Wong WK, Mak C, Lee M, Wong ST, Chan KY, Poon WS (2018) A comparative analysis of the usefulness of survival prediction models for patients with glioblastoma in the temozolomide era: the importance of methylguanine methyltransferase promoter methylation, extent of resection, and subventricular zone location. World Neurosurg 115:e375\u2013e385. https:\/\/doi.org\/10.1016\/j.wneu.2018.04.059","journal-title":"World Neurosurg"},{"key":"1185_CR39","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJMoa0808710","volume":"360","author":"H Yan","year":"2009","unstructured":"Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765\u2013773. https:\/\/doi.org\/10.1056\/NEJMoa0808710","journal-title":"N Engl J Med"},{"key":"1185_CR40","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11060-010-0477-1","volume":"104","author":"GS Young","year":"2011","unstructured":"Young GS, Macklin EA, Setayesh K, Lawson JD, Wen PY, Norden AD, Drappatz J, Kesari S (2011) Longitudinal MRI evidence for decreased survival among periventricular glioblastoma. J Neuro-Oncol 104:261\u2013269. https:\/\/doi.org\/10.1007\/s11060-010-0477-1","journal-title":"J Neuro-Oncol"},{"key":"1185_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068782","volume":"8","author":"P Zou","year":"2013","unstructured":"Zou P, Xu H, Chen P, Yan Q, Zhao L, Zhao P, Gu A (2013) IDH1\/IDH2 mutations define the prognosis and molecular profiles of patients with gliomas: a meta-analysis. PLoS One 8:e68782. https:\/\/doi.org\/10.1371\/journal.pone.0068782","journal-title":"PLoS One"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-019-01185-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10143-019-01185-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-019-01185-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T00:22:36Z","timestamp":1605918156000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10143-019-01185-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,8]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1185"],"URL":"https:\/\/doi.org\/10.1007\/s10143-019-01185-2","relation":{},"ISSN":["0344-5607","1437-2320"],"issn-type":[{"value":"0344-5607","type":"print"},{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,8]]},"assertion":[{"value":"7 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Ethical approval was obtained from the ethics committee at Tokyo Women\u2019s Medical University (No. 3540).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Given the retrospective design, the institutional review board waived the requirement for informed consent. We took the opt-out method. To protect patient privacy, we removed all identifiers from our records upon completion of our analyses.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of informed consent"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}